Karabulut, S. Et Al. 2014. Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma. TUMOR BIOLOGY , vol.35, no.3 , 2729-2739.

Karabulut, S., Duranyildiz, D., Tas, F., Gezer, U., Akyuz, F., Serilmez, M., ... Ozgur, E.(2014). Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma. TUMOR BIOLOGY , vol.35, no.3, 2729-2739.

Karabulut, Sezai Et Al. "Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma," TUMOR BIOLOGY , vol.35, no.3, 2729-2739, 2014

Karabulut, Sezai Et Al. "Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma." TUMOR BIOLOGY , vol.35, no.3, pp.2729-2739, 2014

Karabulut, S. Et Al. (2014) . "Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma." TUMOR BIOLOGY , vol.35, no.3, pp.2729-2739.

@article{article, author={Sezai VATANSEVER Et Al. }, title={Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma}, journal={TUMOR BIOLOGY}, year=2014, pages={2729-2739} }